FDA Licenses ADMET Predictor from Simulations Plus | GenomeWeb
NEW YORK (GenomeWeb News) - Simulations Plus said on Friday that the US Food and Drug Administration has licensed its ADMET Predictor software for use in its Cardiovascular and Renal Products division.
ADMET Predictor predicts approximately 80 properties of molecules, including physicochemical, biopharmaceutical, metabolism, toxicity, and some activity properties,  based on their molecular structure.
Financial terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.